Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Tufton, A. Sahdev, W. Drake, S. Akker (2018)Can subunit‐specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?
Clinical Endocrinology, 90
K. Andrews, D. Ascher, D. Pires, D. Barnes, L. Vialard, R. Casey, N. Bradshaw, J. Adlard, S. Aylwin, P. Brennan, C. Brewer, T. Cole, J. Cook, R. Davidson, A. Donaldson, A. Fryer, L. Greenhalgh, S. Hodgson, R. Irving, F. Lalloo, M. McConachie, V. Mcconnell, P. Morrison, V. Murday, Soo-Mi Park, H. Simpson, K. Snape, S. Stewart, S. Tomkins, Y. Wallis, L. Izatt, D. Goudie, R. Lindsay, C. Perry, E. Woodward, A. Antoniou, E. Maher (2018)Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD
Journal of Medical Genetics, 55
L. Amar, K. Pacak, O. Steichen, S. Akker, S. Aylwin, E. Baudin, A. Buffet, N. Burnichon, R. Clifton-Bligh, P. Dahia, M. Fassnacht, A. Grossman, P. Herman, R. Hicks, A. Januszewicz, C. Jimenez, H. Kunst, D. Lewis, M. Mannelli, M. Naruse, M. Robledo, D. Taïeb, D. Taylor, H. Timmers, G. Treglia, N. Tufton, W. Young, J. Lenders, A. Gimenez-Roqueplo, C. Lussey-Lepoutre (2021)International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
Nature Reviews. Endocrinology, 17
L. Fishbein, K. Nathanson (2012)Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.
Cancer genetics, 205 1-2
A. Buffet, Laurène Aim, S. Leboulleux, D. Drui, D. Vezzosi, R. Libé, C. Ajzenberg, D. Bernardeschi, B. Cariou, F. Chabolle, O. Chabre, V. Darrouzet, B. Delemer, R. Desailloud, B. Goichot, A. Esvant, L. Offredo, P. Herman, S. Laboureau, H. Lefebvre, P. Pierre, I. Raingeard, Y. Reznik, J. Sadoul, J. Hadoux, A. Tabarin, I. Tauveron, D. Zénaty, J. Favier, J. Bertherat, E. Baudin, L. Amar, A. Gimenez-Roqueplo (2019)Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma
The Journal of Clinical Endocrinology & Metabolism, 104
A. Velasco, V. Palomar-Asenjo, L. Gañán, L. Catasús, N. Llecha, A. Panizo, V. Palomar-García, M. Quer, X. Matías-Guiu (2005)Mutation Analysis of the SDHD Gene in Four Kindreds with Familial Paraganglioma: Description of One Novel Germline Mutation
Diagnostic Molecular Pathology, 14
A. Cascón, S. Ruiz-Llorente, A. Cebrián, D. Tellería, J. Rivero, J. Díez, P. López-Ibarra, M. Jaunsolo, J. Benítez, M. Robledo (2002)Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma
European Journal of Human Genetics, 10
K. Jasperson, W. Kohlmann, A. Gammon, H. Slack, L. Buchmann, J. Hunt, A. Kirchhoff, H. Baskin, A. Shaaban, J. Schiffman (2014)Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families
Familial Cancer, 13
J. Bayley, B. Bausch, J. Rijken, L. Hulsteijn, J. Jansen, D. Ascher, D. Pires, F. Hes, E. Hensen, E. Corssmit, P. Devilee, H. Neumann (2019)Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma–paraganglioma
Journal of Medical Genetics, 57
author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law
C. Saie, A. Buffet, J. Abeillon, D. Drui, S. Leboulleux, J. Bertherat, D. Zénaty, C. Storey, F. Borson‐Chazot, N. Burnichon, M. Vincent, J. Favier, E. Baudin, S. Giraud, A. Gimenez-Roqueplo, L. Amar, C. Lussey-Lepoutre (2020)Screening of a large cohort of asymptomatic SDHx mutation carriers in routine practice.
The Journal of clinical endocrinology and metabolism
H. Neumann, Christian Pawlu, M. Peczkowska, B. Bausch, S. McWhinney, M. Mureşan, Mary Buchta, G. Franke, J. Klisch, T. Bley, S. Hoegerle, C. Boedeker, G. Opocher, J. Schipper, A. Januszewicz, C. Eng (2004)Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
JAMA, 292 8
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s)
R. Martins, N. Cunha, H. Simões, M. Matos, João Silva, Isabel Torres, F. Rodrigues, V. Leite, M. Teixeira, Maria Bugalho (2020)Surveillance of succinate dehydrogenase gene mutation carriers: Insights from a nationwide cohort
Clinical Endocrinology, 92
L Fishbein, KL Nathanson (2012)Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background cancer
D. Benn, Ying Zhu, K. Andrews, M. Wilding, E. Duncan, T. Dwight, R. Tothill, J. Burgess, A. Crook, A. Gill, R. Hicks, Edward Kim, C. Luxford, H. Marfan, A. Richardson, B. Robinson, Arran Schlosberg, R. Susman, Lyndal Tacon, A. Trainer, K. Tucker, E. Maher, M. Field, R. Clifton-Bligh (2018)Bayesian approach to determining penetrance of pathogenic SDH variants
Journal of Medical Genetics, 55
S. Greenberg, Michelle Jacobs, H. Wachtel, Amanda Anson, L. Buchmann, D. Cohen, Maria Bonnani, Bonita Bennett, A. Naumer, Amanda Schaefer, W. Kohlmann, K. Nathanson, T. Else, L. Fishbein (2020)Tumor detection rates in screening carriers with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome based on prior tumor history.
Journal of Clinical Oncology, 38
KA Andrews (2018)384
J Med Genet, 55
A. Gimenez-Roqueplo, A. Caumont-Prim, C. Houzard, C. Hignette, A. Hernigou, P. Halimi, P. Niccoli, S. Leboulleux, L. Amar, F. Borson‐Chazot, C. Cardot-Bauters, B. Delemer, F. Chabolle, I. Coupier, R. Libé, M. Peitzsch, S. Peyrard, F. Tenenbaum, P. Plouin, G. Chatellier, V. Rohmer (2013)Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
The Journal of clinical endocrinology and metabolism, 98 1
M. Koenighofer, T. Parzefall, A. Frohne, Elisabeth Frei, C. Schoefer, F. Laccone, P. Feil, K. Frei, T. Lucas (2021)Incomplete penetrance of a novel SDHD variation causing familial head and neck paraganglioma
Clinical Otolaryngology, 46
C. Ricketts, Julia Forman, E. Rattenberry, N. Bradshaw, F. Lalloo, L. Izatt, T. Cole, R. Armstrong, V. Kumar, P. Morrison, A. Atkinson, F. Douglas, S. Ball, J. Cook, U. Srirangalingam, Pip Killick, G. Kirby, S. Aylwin, E. Woodward, D. Evans, S. Hodgson, V. Murday, S. Chew, J. Connell, T. Blundell, F. Macdonald, E. Maher (2010)Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD
Human Mutation, 31
Ángela Cifuentes, M. Arenas, A. Marín-Blázquez (2018)Hereditary paraganglioma-pheochromocytoma syndrome
Medicina Clínica (English Edition)
B. Baysal (2004)Genomic imprinting and environment in hereditary paraganglioma
American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 129C
N. Duinen, Danielle Steenvoorden, B. Bonsing, J. Vuyk, A. Vriends, J. Jansen, J. Romijn, E. Corssmit (2010)Pheochromocytomas detected by biochemical screening in predisposed subjects are associated with lower prevalence of clinical and biochemical manifestations and smaller tumors than pheochromocytomas detected by signs and symptoms.
European journal of endocrinology, 163 1
S. Rednam, A. Erez, H. Druker, K. Janeway, J. Kamihara, W. Kohlmann, K. Nathanson, L. States, G. Tomlinson, A. Villani, S. Voss, J. Schiffman, J. Wasserman (2017)Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood
Clinical Cancer Research, 23
Eleni Daniel, Robert Jones, M. Bull, J. Newell-Price (2016)Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations.
European journal of endocrinology, 175 6
D. Benn, A. Gimenez-Roqueplo, J. Reilly, J. Bertherat, J. Burgess, K. Byth, M. Croxson, P. Dahia, M. Elston, O. Gimm, D. Henley, P. Herman, V. Murday, P. Niccoli-sire, J. Pasieka, V. Rohmer, K. Tucker, X. Jeunemaître, D. Marsh, P. Plouin, B. Robinson (2006)Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
The Journal of clinical endocrinology and metabolism, 91 3
H. Timmers, K. Pacak, J. Bertherat, J. Lenders, M. Duet, G. Eisenhofer, C. Stratakis, P. Niccoli-sire, P. Huy, N. Burnichon, A. Gimenez-Roqueplo (2008)Mutations associated with succinate dehydrogenase d‐related malignant paragangliomas
Clinical Endocrinology, 68
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
N. Tufton, A. Sahdev, S. Akker (2017)Radiological Surveillance Screening in Asymptomatic Succinate Dehydrogenase Mutation Carriers
Journal of the Endocrine Society, 1
Pathogenic variants (PVs) in the SDHD gene increase risk for paragangliomas (PGL)/pheochromocytomas, renal cell carcinomas, and gastrointestinal stromal tumors. Penetrance in individuals with SDHD PVs varies in reported research from 40–70%, and there is limited evidence of specific genotype risks. This study aims to characterize a multi-generational family with SDHD p.Trp43* PVs and potential genotype–phenotype considerations for surveillance. Individuals with a paternally inherited SDHD p.Trp43*(c.129G > A) PV were identified. Genetic, medical and family histories were abstracted, including clinical characteristics, tumor histories, and treatment approaches. Eleven individuals with the SDHD PV in the same kindred were diagnosed with 41 SDHx-related tumors across all family members. Eight individuals developed 27 head and neck PGL of varying origins, and seven individuals developed tumors outside of the head and neck region. Many individuals had multiple tumors, and age of first tumor diagnosis ranged from age 10 to age 45 years old. Individuals with SDHD p.Trp43* variants may have higher risks for SDHx related tumors than other SDHD variants. Prioritizing identification of at-risk individuals and initiating surveillance tailored to family history is recommended given the rate of multiple tumors found in one familial branch of individuals under 18 years old. Individuals with strong family histories of PGL at young ages with this PV will benefit from tailored surveillance recommendations.
Familial Cancer – Springer Journals
Published: Apr 1, 2023
Keywords: SDHx; Pheochromocytoma; Tumor predisposition; Succinate dehydrogenase; Genetics; Germline mutation
Access the full text.
Sign up today, get DeepDyve free for 14 days.